DA secures US$ 40.8m series C1 extension round for secondary care | Healthcare Asia Magazine
, Singapore

DA secures US$ 40.8m series C1 extension round for secondary care

The funds were from participating investors Square Peg and Novo Holdings.

Doctor Anywhere (DA), a Singapore-based tech-led healthcare company, said it raised 40.8 million Series C1 extension round with investors Square Peg and Novo Holdings.

The funds will be used for healthcare innovation and to deepen its presence in secondary care.

"The company is set to intensify efforts on product innovation in building a vertically integrated digital healthcare ecosystem. This ecosystem will cater to the rising demand for comprehensive and connected healthcare solutions that prioritise patient experiences and outcomes," read the statement.

Doctor Anywhere has deployed advanced tech in healthcare such as first online supervised tele-antigen rapid testing (ART) service. 

Join Healthcare Asia Magazine community
Since you're here...

...there are many ways you can work with us to advertise your company and connect to your customers. Our team can help you dight and create an advertising campaign, in print and digital, on this website and in print magazine.

We can also organize a real life or digital event for you and find thought leader speakers as well as industry leaders, who could be your potential partners, to join the event. We also run some awards programmes which give you an opportunity to be recognized for your achievements during the year and you can join this as a participant or a sponsor.

Let us help you drive your business forward with a good partnership!